Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease

Objective. Anxiety and depression have a negative influence in the quality of life. The aim of the study was to determinate the levels of sensitivity and specificity of the Anxiety and Hospital Depression Scale (HADS) and compare the quality of life in patients with inflammatory bowel disease (IBD)...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jesús K. Yamamoto-Furusho, Katya E. Bozada Gutiérrez, Andrea Sarmiento-Aguilar, Ana Fresán-Orellana, Perla Arguelles-Castro, Mario García-Alanis
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Psychiatry RC435-571
Acceso en línea:	https://doaj.org/article/b0c051c18d0b452e95d3158d586cd558
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b0c051c18d0b452e95d3158d586cd558
record_format	dspace
spelling	oai:doaj.org-article:b0c051c18d0b452e95d3158d586cd5582021-11-08T02:36:50ZDepression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease2314-433510.1155/2021/5540786https://doaj.org/article/b0c051c18d0b452e95d3158d586cd5582021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5540786https://doaj.org/toc/2314-4335Objective. Anxiety and depression have a negative influence in the quality of life. The aim of the study was to determinate the levels of sensitivity and specificity of the Anxiety and Hospital Depression Scale (HADS) and compare the quality of life in patients with inflammatory bowel disease (IBD) and depression or anxiety. Methods. This study included 104 patients with diagnosis of IBD. Each patient received psychiatric intervention with SCID-I (Structured Clinical Interview for DSMIV Axis I Disorders) instrument as a gold standard to stablish the cut-off points of HADS. Quality of life was also evaluated with IBDQ-32. Demographic and clinical variables were collected. Results. Most of the patients reported a high quality of life (73.1%, n=76), while 25.0% (n=26) express a moderate quality of life. The ROC curves for both psychiatric entities showed an adequate discriminative capacity of the HADS-anxiety dimension (AUC=0.84, 95%CI=0.76-0.92) with a limited discriminability of the HADS-depression dimension (AUC=0.58, 95%CI=0.46-0.70) using the proposed scoring of 8 as a cut-off point. Conclusions. Anxiety and depression impact negatively in the quality of life in Mexican patients with IBD. The Mexican version of HADS had acceptable internal consistency and external validity, with moderate sensitivity and specificity for clearly identifying clinical cases of anxiety and depression in patients with IBD.Jesús K. Yamamoto-FurushoKatya E. Bozada GutiérrezAndrea Sarmiento-AguilarAna Fresán-OrellanaPerla Arguelles-CastroMario García-AlanisHindawi LimitedarticlePsychiatryRC435-571ENPsychiatry Journal, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Psychiatry RC435-571
spellingShingle	Psychiatry RC435-571 Jesús K. Yamamoto-Furusho Katya E. Bozada Gutiérrez Andrea Sarmiento-Aguilar Ana Fresán-Orellana Perla Arguelles-Castro Mario García-Alanis Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
description	Objective. Anxiety and depression have a negative influence in the quality of life. The aim of the study was to determinate the levels of sensitivity and specificity of the Anxiety and Hospital Depression Scale (HADS) and compare the quality of life in patients with inflammatory bowel disease (IBD) and depression or anxiety. Methods. This study included 104 patients with diagnosis of IBD. Each patient received psychiatric intervention with SCID-I (Structured Clinical Interview for DSMIV Axis I Disorders) instrument as a gold standard to stablish the cut-off points of HADS. Quality of life was also evaluated with IBDQ-32. Demographic and clinical variables were collected. Results. Most of the patients reported a high quality of life (73.1%, n=76), while 25.0% (n=26) express a moderate quality of life. The ROC curves for both psychiatric entities showed an adequate discriminative capacity of the HADS-anxiety dimension (AUC=0.84, 95%CI=0.76-0.92) with a limited discriminability of the HADS-depression dimension (AUC=0.58, 95%CI=0.46-0.70) using the proposed scoring of 8 as a cut-off point. Conclusions. Anxiety and depression impact negatively in the quality of life in Mexican patients with IBD. The Mexican version of HADS had acceptable internal consistency and external validity, with moderate sensitivity and specificity for clearly identifying clinical cases of anxiety and depression in patients with IBD.
format	article
author	Jesús K. Yamamoto-Furusho Katya E. Bozada Gutiérrez Andrea Sarmiento-Aguilar Ana Fresán-Orellana Perla Arguelles-Castro Mario García-Alanis
author_facet	Jesús K. Yamamoto-Furusho Katya E. Bozada Gutiérrez Andrea Sarmiento-Aguilar Ana Fresán-Orellana Perla Arguelles-Castro Mario García-Alanis
author_sort	Jesús K. Yamamoto-Furusho
title	Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
title_short	Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
title_full	Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
title_fullStr	Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
title_full_unstemmed	Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
title_sort	depression and anxiety disorders impact in the quality of life of patients with inflammatory bowel disease
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/b0c051c18d0b452e95d3158d586cd558
work_keys_str_mv	AT jesuskyamamotofurusho depressionandanxietydisordersimpactinthequalityoflifeofpatientswithinflammatoryboweldisease AT katyaebozadagutierrez depressionandanxietydisordersimpactinthequalityoflifeofpatientswithinflammatoryboweldisease AT andreasarmientoaguilar depressionandanxietydisordersimpactinthequalityoflifeofpatientswithinflammatoryboweldisease AT anafresanorellana depressionandanxietydisordersimpactinthequalityoflifeofpatientswithinflammatoryboweldisease AT perlaarguellescastro depressionandanxietydisordersimpactinthequalityoflifeofpatientswithinflammatoryboweldisease AT mariogarciaalanis depressionandanxietydisordersimpactinthequalityoflifeofpatientswithinflammatoryboweldisease
_version_	1718443129408847872

Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease

Ejemplares similares